A practical checklist covering licences, raw material certificates, COA requirements, and packaging standards for buyers procuring bulk Ras-Rasayan tablets.
Before committing to a bulk order of Ras-Rasayan tablets, confirm that the manufacturer holds valid GMP and AYUSH licences, can supply incoming material certificates for each bhasma lot, provides a complete certificate of analysis for every finished batch, and uses packaging validated for mineral preparations. These four checks protect product quality and downstream regulatory standing.
Ras-Rasayan preparations are classified as Ayurvedic drugs under the Drugs and Cosmetics Act, 1940, because they contain processed mineral ingredients, chiefly bhasma. Commercial manufacture requires a valid AYUSH manufacturing licence from the state licensing authority and compliance with Schedule T GMP conditions as set out in the Drugs and Cosmetics Rules. Buyers are entitled to request copies of both documents before placing any order, and a supplier who cannot produce current, legible copies should not be shortlisted.
A GMP certificate under Schedule T confirms that the facility has been inspected for documented batch manufacturing records, hygiene and housekeeping standards, qualified personnel, calibrated equipment, and systematic stability monitoring. For Ras-Rasayan tablets, these controls matter more than for plain herbal products because improperly processed bhasma is a quality and safety concern, not merely a consistency issue. Confirm that the licence is currently valid, covers the specific formulation category you need, and is not under a renewal condition or show-cause notice.
If the product will be positioned as a food supplement rather than a scheduled Ayurvedic drug, FSSAI registration becomes the controlling document instead. For classical mineral formulations, the AYUSH licence is the appropriate framework. Mixing regulatory categories on a single product label creates compliance exposure, so clarify the applicable framework with your own regulatory counsel before finalising supply terms.
The quality of finished Ras-Rasayan tablets depends directly on the quality of the bhasma used in production. Bhasma preparation involves repeated calcination and quenching in specific plant decoctions, as described in classical texts such as Rasa Tarangini and Rasa Ratna Samucchaya. A GMP manufacturer should maintain incoming material test records for every bhasma lot, traceable to batch number and receipt date, and should make these available to buyers on request.
Ask for certificates of analysis covering the key mineral ingredients. These should address identity tests, loss on drying, total ash, heavy metal profiles including lead, arsenic, cadmium, and mercury, and microbial limit checks. If a supplier cannot produce incoming material COAs, the finished-product certificate carries limited evidential value because there is no documented chain linking raw material quality to the final tablet. Buyers supplying export markets should also ask whether the manufacturer benchmarks raw materials against the Ayurvedic Pharmacopoeia of India, which publishes reference standards for many classical mineral ingredients.
A certificate of analysis for bulk Ras-Rasayan tablets should address physical description, tablet weight uniformity, disintegration profile, loss on drying, total ash and acid-insoluble ash, heavy metal screen covering at minimum lead, arsenic, cadmium, and mercury, and microbial limit tests including total viable aerobic count and absence of specified pathogens. Where a pharmacopoeial monograph specifies marker compound assay values, these should also appear in the document.
Require the COA to reference the specific batch number, manufacturing date, and retest or expiry date of the lot being supplied. A generic or undated COA provides no traceability and cannot support downstream regulatory submissions. Clarify whether testing was conducted in-house, at an NABL-accredited external laboratory, or both. Many GMP manufacturers run primary in-house testing and confirm critical parameters at an accredited third-party facility, particularly for export consignments.
Buyers planning to white-label the product should also request a complete excipient declaration from the supplier. This information is required to populate label descriptions accurately under Drugs and Cosmetics Act labelling rules and avoids complications when retail label proofs or regulatory filings require full ingredient disclosure. The declaration should include all binders, disintegrants, coatings, and any polishing agents used in tablet manufacture.
Ras-Rasayan tablets containing processed minerals are sensitive to humidity and oxidation over time. Packaging acceptable for herbal churna may be inadequate for bhasma-based tablets with a target shelf life of two or more years. Ask the manufacturer what primary packaging is proposed: HDPE containers with desiccant sachets, aluminium-foil blister packs, and amber glass containers are all established formats for mineral preparations. Confirm that the selection is backed by stability data, not merely by convention.
Bulk B2B consignments typically use double-lined fibre drums or HDPE pails with inner polyethylene liner bags. Verify that moisture vapour transmission through the proposed bulk pack is consistent with the stated retest period. If you plan to brand the product under your own label, confirm whether the supplier offers private-label production, generic bulk supply, or both, and clarify export documentation capability before agreeing to terms.
The most reliable way to evaluate a new Ras-Rasayan tablet supplier is a structured sample-to-commercial-batch process. Request a laboratory sample first and test it independently against the supplier's COA. If results align, commission a small commercial trial batch and store a portion under ICH Zone IVb conditions, which represent 40 degrees C and 75% relative humidity, to verify stability claims over a realistic duration before committing to full volume.
A supplier confident in their process will provide pre-shipment samples from the actual production batch, not from a separate demonstration run. Document the sampling protocol, retain reference samples on both sides, and confirm in writing the batch number to which the samples correspond. This retained-sample discipline provides a clear reference point if any dispute about batch consistency arises with later orders. Ask whether the supplier can name the NABL-accredited laboratory they use for third-party confirmation, as this detail matters for export regulatory submissions in several destination markets and for domestic institutional tender requirements.
Raasa Ayurveda manufactures Ras-Rasayan formulations from its GMP-certified Kanpur facility under AYUSH manufacturing licence A-4177/2009 and GMP certificate D-5755/09. Samples are provided before any bulk commitment, and a certificate of analysis accompanies every consignment. To discuss your formulation requirements, preferred packaging format, and documentation needs, reach the team via bulk supply or contract manufacturing enquiry. Call +91 9415128217 or write to raasaayurveda@gmail.com.
Any commercial manufacturer must hold a valid AYUSH manufacturing licence from their state authority and operate under Schedule T GMP conditions. Ask to see both documents, confirm the licence is current and covers the specific formulation category you need, and check that the GMP certificate has not lapsed or been suspended or renewed under conditions.
At minimum, the certificate of analysis should report values for lead, arsenic, cadmium, and mercury. These four are the standard screen for mineral-based Ayurvedic preparations and are the parameters most commonly required by Indian and international regulatory submissions. Some export markets additionally require nickel or chromium screening depending on the destination country.
Request incoming material certificates of analysis for each bhasma lot used in the batch. These should include identity tests, ash value, loss on drying, and heavy metal profiles. Where the formulation references a specific bhasma grade, ask whether the supplier follows Ayurvedic Pharmacopoeia of India standards for that ingredient and can supply the relevant test records.
Many GMP manufacturers offer private-label capability alongside generic bulk supply. Confirm this before placing an order. You will need to supply label artwork compliant with Drugs and Cosmetics Act labelling rules, and the manufacturer will need to confirm whether they can accommodate your preferred packaging format and the required minimum batch quantity for that format.
Raasa Ayurveda, 49/72-A, Naughara, Kanpur 208001, Uttar Pradesh, India. Telephone +91 9415128217. Email raasaayurveda@gmail.com.